SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-024840
Filing Date
2021-02-17
Accepted
2021-02-17 16:40:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a21-5730_2sc13da.htm SC 13D/A 44211
  Complete submission text file 0001104659-21-024840.txt   45668
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90737 | Film No.: 21645437
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 ATHOL STREET DOUGLAS Y8 IM1 1JA
Business Address 18 ATHOL STREET DOUGLAS Y8 IM1 1JA 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y8 | Fiscal Year End: 1231
Type: SC 13D/A